Skip to Main Content

Paper Details

Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease.
Int J Hematol
4
2023
CV death, CVD, ET, MPN, PH, PMF, PV, Pulmonary hypertension, atrial fibrillation, cardiovascular death, cardiovascular disease, heart failure, leukemia, myelofibrosis, myeloproliferative neoplasms, myocardial infarction, patients
Author NameAffiliation
Donna NeubergDana-Farber Cancer Institute
Rachel P RosovskyMassachusetts General Hospital and Harvard Medical School
  • 1 - 2

Datasets

Release 1.2